Smartkarma Research

We are tasked to build the supply-side of the Smartkarma Research Network.  Our goals:
1. Build an array of easy to market and sell research products with wide appeal and high aspirational value
2. These research products should be: 
a) Dollar Dense
b) Differentiated
c) Data-Driven
d) Must have strong network effects (virality)

The Research Team works closely with our Insight Provider base as well as internal teams: 
a) Marketing: to drive appeal and awareness
b) Sales: to drive revenue and engagement
d) Technology: to drive discoverability, curation, supply, improve payment infra

Smartkarma Research Team

Actionable bottom-up long/short Insights on equities

Equity Bottom-Up

Hyphens Pharma International Limited is Singapore’s leading specialty pharmaceutical and consumer healthcare group. 

It develops and owns several dermatological products and supplements, such as Ceradan, TDF and Ocean Health. 

The Group also markets and sells specialty pharmaceutical products through exclusive agreements, as well as operates an online B2B platform for healthcare professionals. 

Please visit us at https://www.hyphensgroup.com for more information.

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Hyphens Pharma International

Smartkarma Corporate Webinar | Hyphens Pharma: Deepening Presence in ASEAN